BRIEF-Aikido Pharma Reviewed Proposal From Shalom Auerbach And Determined It Was Not Interested In Pursuing Offer

Reuters2022-08-19

Aug 19 (Reuters) - Aikido Pharma Inc :

* AIKIDO PHARMA - REVIEWED PROPOSAL FROM SHALOM AUERBACH AND DETERMINED IT WAS NOT INTERESTED IN PURSUING OFFER

* AIKIDO PHARMA INC - REVIEWED UNSOLICITED PROPOSAL FROM SHALOM AUERBACH TO ACQUIRE ALL OF OUTSTANDING SHARES OF COMPANY FOR $8.00 PER SHARE IN CASH

Source text for Eikon: [ Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2260337372?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2022-08-20 05:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2260337372","market":"us","top_or_hot":-1,"title":"BRIEF-Aikido Pharma Reviewed Proposal From Shalom Auerbach And Determined It Was Not Interested In Pursuing Offer","media":"Reuters","content":"<html><body><p>Aug 19 (Reuters) - Aikido Pharma Inc   :</p><p>   * AIKIDO PHARMA - REVIEWED PROPOSAL FROM SHALOM AUERBACH AND DETERMINED IT WAS NOT INTERESTED IN PURSUING OFFER</p><p>   * AIKIDO PHARMA INC - REVIEWED UNSOLICITED PROPOSAL FROM SHALOM AUERBACH TO ACQUIRE ALL OF OUTSTANDING SHARES OF COMPANY FOR $8.00 PER SHARE IN CASH</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Aikido Pharma Reviewed Proposal From Shalom Auerbach And Determined It Was Not Interested In Pursuing Offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Aikido Pharma Reviewed Proposal From Shalom Auerbach And Determined It Was Not Interested In Pursuing Offer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-08-20 05:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Aug 19 (Reuters) - Aikido Pharma Inc   :</p><p>   * AIKIDO PHARMA - REVIEWED PROPOSAL FROM SHALOM AUERBACH AND DETERMINED IT WAS NOT INTERESTED IN PURSUING OFFER</p><p>   * AIKIDO PHARMA INC - REVIEWED UNSOLICITED PROPOSAL FROM SHALOM AUERBACH TO ACQUIRE ALL OF OUTSTANDING SHARES OF COMPANY FOR $8.00 PER SHARE IN CASH</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2260337372","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2260337372","pubTimestamp":1660944860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Aug 19 (Reuters) - Aikido Pharma Inc   :   * AIKIDO PHARMA - REVIEWED PROPOSAL FROM SHALOM AUERBACH ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"简讯-合气道制药公司审查了沙洛姆奥尔巴赫的提议，并确定它对追求报价不感兴趣","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AIKI":0.9,"APR":0.9,"CGEM":0.9,"LABP":0.9,"LHDX":0.9,"ONTF":0.9,"SANA":0.9},"content_text":"Aug 19 (Reuters) - Aikido Pharma Inc   :   * AIKIDO PHARMA - REVIEWED PROPOSAL FROM SHALOM AUERBACH AND DETERMINED IT WAS NOT INTERESTED IN PURSUING OFFER   * AIKIDO PHARMA INC - REVIEWED UNSOLICITED PROPOSAL FROM SHALOM AUERBACH TO ACQUIRE ALL OF OUTSTANDING SHARES OF COMPANY FOR $8.00 PER SHARE IN CASHSource text for Eikon: [ Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2260337372"}